Abstract
Background: Pancreatic stellate cells (PSCs) play a crucial role in chronic pancreatitis. However, the effects of tobacco-derived carcinogens on PSC activation remain poorly understood. This study aimed to investigate the impact of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a predominant tobacco-specific nitrosamine, on PSC activation. Methods: A cerulein-induced chronic pancreatitis (CP) mouse model was established, and mice were treated with NNK to evaluate pancreatic injury and fibrosis in vivo. Human- and mouse-derived PSCs were treated with NNK in vitro. Cell metabolic activity was assessed using the CCK-8 assay, and activation-associated marker expression was evaluated by detecting the protein and mRNA levels of the activation marker α-smooth muscle actin (α-SMA) using Western blot and quantitative PCR (qPCR). Transcriptome sequencing was performed on PSCs with or without NNK treatment for preliminary screening of expression-altered genes. Intersection analysis was then conducted on gene sets satisfying raw p < 0.05 from both human and mouse PSCs to obtain cross-species overlapping candidate genes. Results: NNK administration aggravated pancreatic injury, collagen deposition, and α-SMA expression in cerulein-induced CP mice. In cultured PSCs, NNK treatment significantly increased cellular metabolic activity assessed by the CCK-8 assay and upregulated the expression of α-SMA, a canonical marker of PSC activation. Transcriptomic preliminary screening yielded six consistently upregulated candidates (NMI, SLC16A6, KLHDC1, TNFSF13, RGS1, and the non-coding RNA SNORA31) and three downregulated candidates (PRR7, PPP1R14B, and NR2F6) across species. The qPCR results were largely consistent with the RNA-seq observations for the majority of protein-coding candidates, yet two out of eight protein-coding candidates showed discordant expression in hPSCs, providing technical confirmation of the transcriptomic screening findings. No multiple-testing correction was applied for initial transcriptomic screening. Conclusions: NNK enhanced activation-associated marker expression in cultured PSCs and aggravated pancreatic injury and fibrosis in cerulein-induced CP mice, accompanied by overlapping transcriptional changes between human and mouse PSCs obtained via preliminary screening using raw p values without multiple-testing correction. The obtained candidate genes may provide potential molecular clues for NNK-mediated PSC phenotypic alterations in tobacco-associated pancreatic diseases. Further functional characterization of these cross-species candidate genes may facilitate the development of therapeutic strategies targeting smoking-related chronic pancreatitis and tobacco-associated pancreatic disorders.